Puma Biotechnology Inc (PBYI)
PBYI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.12
-1.65% on the day
Market cap
$522.4M
Small cap
Revenue · 2025
$228.4M
-0.9% on 2024
Net income · 2025
$31.1M
13.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PBYI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001401667 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $228.4M |
| Net income | $31.1M |
| Operating income | $37.3M |
| Net margin | 13.6% |
| Operating margin | 16.3% |
| Revenue growth | -0.9% |
| Cash | $29.6M |
| Total assets | $216.3M |
| P/E (computed) | 16.8× |
| P/S (computed) | 2.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2022-08-02 |
| Latest annual report FORM 10-K | 10-K | 2026-02-26 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-08-06 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.3% |
| 1 month | +10.6% |
| 3 months | +21.8% |
| Year to date | +71.9% |
| 1 year | +93.4% |
| From 52-week high | -0.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | $3.47 | -3.61% | $510.8M |
| MPLT | MapLight Therapeutics Inc. | $7.88 | -8.43% | $510.1M |
| CTMX | CytomX Therapeutics Inc. | $2.33 | -3.93% | $506.6M |
| DRUG | Bright Minds Biosciences Inc. | $51.36 | -4.91% | $504.3M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
| STTK | Shattuck Labs Inc. | $5.49 | -9.85% | $551.0M |
| SLN | Silence Therapeutics Plc American Depository Share | $8.87 | -8.08% | $551.3M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier